» Articles » PMID: 21280033

Hospital-related Morbidity Among Childhood Cancer Survivors in British Columbia, Canada: Report of the Childhood, Adolescent, Young Adult Cancer Survivors (CAYACS) Program

Overview
Journal Int J Cancer
Specialty Oncology
Date 2011 Feb 1
PMID 21280033
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Our study examines inpatient, hospital-related morbidity in a geographically-defined cohort of long-term cancer survivors diagnosed before age 20 years in the province of British Columbia (BC), Canada. A total of 1374 survivors diagnosed from 1981 to 1995 surviving at least 5-years postdiagnosis, and a matched sample of 13,740 BC residents, were identified from population registers, and linked to provincial hospitalization records from 1986 to 2000. Logistic regression was used to assess relative risk and effect of sociodemographic, clinical, and temporal factors on risk. Approximately 41% of survivors vs. 17% of the population sample had at least one type of hospitalization-related late morbidity in the observation period (adjusted RR 4.1, 95% CI 3.7-4.5). Those at highest risk were survivors of leukemia (RR 4.8, 95% CI 4.0-5.8), central nervous system tumors (RR 4.8, 95% CI 4.0-5.8), bone and soft tissue sarcomas (RR 4.9, 95% CI 3.8-6.2), and kidney cancer (RR 4.9, 95% CI 3.4-7.0). Adjusted relative risk was elevated for all types of morbidity except pregnancy and birth complications, and highest for neoplasms (including second primary cancers) (RR 21.7, 95% CI 16.3-28.7). Morbidity was elevated for all combinations of primary treatment and highest for those with previous radiation, chemotherapy, and surgery (RR 7.1, 95% CI 5.5-9.0). Over time, morbidity for late effects other than neoplasms became more prevalent. These results suggest that survivors are at increased ongoing risk of many types of hospital-related late morbidity, implying that long-term monitoring for multiple health problems is warranted.

Citing Articles

Role of GPCR Signaling in Anthracycline-Induced Cardiotoxicity.

Biswal N, Harish R, Roshan M, Samudrala S, Jiao X, Pestell R Cells. 2025; 14(3).

PMID: 39936961 PMC: 11817789. DOI: 10.3390/cells14030169.


Late Complications in Long-Term Childhood Cancer Survivors: What the Oral Health Professional Needs to Know.

Al-Ansari S, Stolze J, Bresters D, Brook A, Laheij A, Brand H Dent J (Basel). 2024; 12(1).

PMID: 38275678 PMC: 10813876. DOI: 10.3390/dj12010017.


Cardiac electrical abnormalities in childhood acute lymphoblastic leukemia survivors: a systematic review.

Bertrand E, Caru M, Harvey A, Dodin P, Jacquemet V, Curnier D Cardiooncology. 2023; 9(1):40.

PMID: 37950323 PMC: 10638753. DOI: 10.1186/s40959-023-00188-9.


Long-term hospitalisations in survivors of paediatric solid tumours in France.

Bejarano-Quisoboni D, Pelletier-Fleury N, Allodji R, Fresneau B, Boussac M, Pacquement H Sci Rep. 2022; 12(1):18068.

PMID: 36302943 PMC: 9613884. DOI: 10.1038/s41598-022-22689-w.


Long-term diagnosis-specific sickness absence, disability pension, and healthcare use in 1305 young adult childhood cancer survivors and in 6430 references; a Swedish ten-year prospective cohort study.

Baecklund F, Alexanderson K, Chen L PLoS One. 2022; 17(9):e0275343.

PMID: 36178911 PMC: 9524675. DOI: 10.1371/journal.pone.0275343.